Drugs Health Pharma

Astellas’ prostate cancer drug for metastasis-free survival gets nod

HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of.

Read More
Drugs Health Pharma

FDA clears home test for chlamydia, gonorrhea in US as infections rise

HQ Team November 16, 2023: The USFDA has approved a first test for chlamydia and gonorrhea that will allow people to collect samples.

Read More
Drugs Health Pharma

Valneva’s chikungunya jab gets FDA nod, first such for disease

HQ Team November 10, 2023: Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals.

Read More
Drugs Health Pharma

US, UK regulators give green light to Eli Lilly’s weight-loss treatment

HQ Team November 9, 2023: Eli Lilly’s weight-loss injection Zepbound, to be taken along as a supplement with diet and exercise, got the.

Read More
Health Medical Pharma

Otsuka Medical gets USFDA nod for treatment of hypertension  

Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.

Read More
Drugs Health Pharma

US regulator may ban brominated vegetable oil in food products

HQ Team November 6, 2023: The USFDA plans to revoke a regulation authorising the use of brominated vegetable oil in food as it.

Read More
Drugs Health Pharma

FDA warns against use of certain OTC eye drop products

HQ Team October 31, 2023: The US Food and Drug Administration has warned consumers not to use certain over-the-counter eye drop products due.

Read More
Drugs Health Pharma

BioMarin’s achondroplasia drug gets nod for children of all ages

HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.

Read More
Drugs Health Pharma

Pfizer’s vaccine for meningococcal disease gets FDA approval

HQ Team October 21, 2023: The USFDA has approved Pfizer Inc.’s vaccine to treat deadly meningococcal disease in young adults between 10 years.

Read More
Drugs Health Pharma

Belgium’s Hyloris gets nod for post-operative pain reduction drug

HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative.

Read More